Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome

por Araki, Tetsuro, Dahlberg, Suzanne E., Hida, Tomoyuki, Lydon, Christine A., Rabin, Michael S., Hatabu, Hiroto, Johnson, Bruce E., Nishino, Mizuki
Publicado 2019

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome

por Park, Hyesun, Dahlberg, Suzanne E., Lydon, Christine A., Araki, Tetsuro, Hatabu, Hiroto, Rabin, Michael S., Johnson, Bruce E., Nishino, Mizuki
Publicado 2019

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

por Nishino, Mizuki, Hida, Tomoyuki, Kravets, Sasha, Dahlberg, Suzanne E., Lydon, Christine A., Hatabu, Hiroto, Johnson, Bruce E., Awad, Mark M.
Publicado 2020

Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer

por Awad, Mark M., Mastini, Cristina, Blasco, Rafael B., Mologni, Luca, Voena, Claudia, Mussolin, Lara, Mach, Stacy L., Adeni, Anika E., Lydon, Christine A., Sholl, Lynette M., Jänne, Pasi A., Chiarle, Roberto
Publicado 2017

The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute

por Tolaney, Sara M, Lydon, Christine A, Li, Tianyu, Dai, Jiale, Standring, Andrea, Legor, Kristen A, Caparrotta, Caryn M, Schenker, Matthew P, Glazer, Daniel I, Tayob, Nabihah, DuBois, Steven G, Meyerhardt, Jeffrey A, Taplin, Mary-Ellen, Johnson, Bruce E
Publicado 2020